Paper Review Records
全部论文审稿周期
11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
90
天
214
天
SDC2 promotes gemcitabine resistance of bladder cancer via activation of the EGFR-ERK-C-MYC axis mediated epithelial-mesenchymal transition
作者
Zhiyuan Mi; Jinkun Wu; Xintao Tian; Guipeng Wang; Shuaishuai Li; Guofeng Ma; Zhijuan Liang; Dan Li; Yuanbin Chen; Liping Wang; Ye Liang; Haitao Niu展开收起
作者单位
1. The Affiliated Hospital of Qingdao University; 2. Yantai Yuhuangding Hospital of Qingdao University; 3. The Afffliated Hospital of Qingdao University展开收起
60
天
From single-pathway reporters to integrated sensors: molecular imaging challenges in detecting PANoptosis
作者
Kulsoom; Wajahat Ali; Latofatoy Nurislomova; Gulmira Ibrohimova; Otabek Kuziev; Jumaniyozov Kuvondik; Jasurbek Mamajonov展开收起
作者单位
1. Xi’an Jiaotong University; 2. Termez University of Economics and Service; 3. Alfraganus University; 4. Mamun University; 5. Kokand University Andijan Branch展开收起
139
天
116
天
250
天
Meta-analysis of NPC2-mediated cholesterol transport in human cancers as a prognostic biomarker with therapeutic implications
作者
Francisco Cezar Aquino de Moraes; Luis Henrique Rios Moreira Rego; Emanuele Rocha da Silva; Rosario Dominguez Crespo Hirata; Rommel Mario Rodriguez Burbano; Mario Hiroyuki Hirata展开收起
作者单位
1. Federal University of São Paulo; 2. State University of Piauí; 3. University of Sao Paulo; 4. Federal University of Pará展开收起
FAQ
CELL CYCLE审稿要多久?
截至2026-11-19,CrushSCI 收录了 CELL CYCLE 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 55 天(Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment,2026-07-02 收稿,2026-08-26 录用),最慢一篇用了 327 天;平均 152.5 天,中位数 139 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
